ISU ABXIS CO., LTD.

Highlights ISU Abxis Co., Ltd.

Equities

A086890

KR7086890001

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-27 EDT			5-day change	1st Jan Change
6,610 ^KRW	-0.30%		-6.51%	+9.26%

2023	ISU Abxis Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Eucure Biopharma Announces Partnership with ISU ABXIS for the Development of Tri-specific Antibodies using YH003 Antibody Sequence	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ISU Abxis Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Eucure Biopharma Announces Partnership with ISU ABXIS for the Development of Tri-specific Antibodies using YH003 Antibody Sequence	22-10-31	CI
A group of buyers acquired 5.8% stake of ISU Abxis Co., Ltd. from Saneun Capital Co., Ltd. for KRW 17.1 billion.	20-09-21	CI
Catalyst Biosciences, Inc. and ISU Abxis to Initiate Phase I/II hemophilia B study	17-04-10	CI
Catalyst Biosciences, Inc. and Isu Abxis Form Strategic Collaboration	13-10-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer